ABVX · Abivax ADR
United States · RS rating 11 · As of 2026-10-14
| Price | 87.98 USD |
|---|---|
| 1-day change | +2.0% |
| RS rating (overall / 1M / 3M / 12M) | 11 / 13 / 9 / 34 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 33 / 4 / 29 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -141.0% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +39.5% |
| Market cap (USD) | $9.0B |